The estimated Net Worth of Paulo F Costa is at least $411 mil dollars as of 3 March 2016. Mr. Costa owns over 10,000 units of CorMedix Inc stock worth over $410,696 and over the last 11 years he sold CRMD stock worth over $0. In addition, he makes $0 as Director at CorMedix Inc.
Paulo has made over 2 trades of the CorMedix Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of CRMD stock worth $172,000 on 3 March 2016.
The largest trade he's ever made was buying 10,000 units of CorMedix Inc stock on 3 March 2016 worth over $172,000. On average, Paulo trades about 1,176 units every 0 days since 2013. As of 3 March 2016 he still owns at least 59,435 units of CorMedix Inc stock.
You can see the complete history of Mr. Costa stock trades at the bottom of the page.
Paulo F. Costa serves as Director of the Company. He served as President and Chief Executive Officer of Novartis U.S. Corporation, from October 2005 to August 2008. Prior to his work at Novartis U.S. Corporation, Mr. Costa was President and Chief Executive Officer of Novartis Pharmaceuticals, U.S. from July 1999 to September 2005. Prior to joining Novartis, Mr. Costa spent 30 years at Johnson & Johnson, including as President of Janssen Pharmaceutica, Inc. From August 2009 to August 2012, Mr. Costa served as Chairman of the Board of Amylin Pharmaceuticals Inc, a commercial stage biopharma company, until its sale to Bristol-Myers Squibb and AstraZeneca in a $7 billion transaction in 2012. Mr. Costa currently serves as Chairman of the Board of MacroGenics, Inc., a public late stage biopharma company focused on oncology, and as a director of two privately held life science companies.
Paulo Costa is 70, he's been the Director of CorMedix Inc since 2020. There are 4 older and 9 younger executives at CorMedix Inc. The oldest executive at CorMedix Inc is John L. Armstrong Jr., 76, who is the Exec. VP for Technical Operations.
Paulo's mailing address filed with the SEC is C/O CORMEDIX INC., 300 CONNELL DRIVE, BERKELEY HEIGHTS, NJ, 07922.
Over the last 15 years, insiders at CorMedix Inc have traded over $693,980 worth of CorMedix Inc stock and bought 2,651,866 units worth $3,532,566 . The most active insiders traders include Mehmood Khan, Gary A. Gelbfish, eBrian Lenz. On average, CorMedix Inc executives and independent directors trade stock every 30 days with the average trade being worth of $199,105. The most recent stock trade was executed by Joseph Todisco on 13 March 2024, trading 13,561 units of CRMD stock currently worth $50,718.
cormedix inc. is a company based out of 745 route 202-206, suite 303, bridgewater, nj, united states.
CorMedix Inc executives and other stock owners filed with the SEC include: